InvestSMART

Orthocell Limited (ASX: OCC) - Announcements

Current share price for OCC : $0.570 0.02 (3.64%)+

ASX company news and announcements for Orthocell Limited (OCC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Orthocell Limited (OCC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Orthocell Limited (OCC), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Orthocell Limited (OCC)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$155 Appendix 3Y - Michael McNulty 13 Nov 2026 8:25AM $0.575 $0.570 fallen by 0.87%
$155 Notification regarding unquoted securities - OCC 10 Nov 2026 6:17PM $0.595 $0.570 fallen by 4.20%
$155 Option Terms and Conditions 10 Nov 2026 2:55PM $0.590 $0.570 fallen by 3.39%
$155 Proposed issue of securities - OCC 10 Nov 2026 2:52PM $0.590 $0.570 fallen by 3.39%
$155 Appendix 3Y - John Van Der Wielen 10 Nov 2026 8:57AM $0.590 $0.570 fallen by 3.39%
$155 Amended Constitution 6 Nov 2026 4:19PM $0.575 $0.570 fallen by 0.87%
$155 Results of Annual General Meeting 6 Nov 2026 2:49PM $0.575 $0.570 fallen by 0.87%
$155 AGM Addresses by Chair and Managing Director 6 Nov 2026 9:35AM $0.555 $0.570 risen by 2.70%
$155 Marine Biomedical Achieves FDA Clearance 3 Nov 2026 10:09AM $0.575 $0.570 fallen by 0.87%
$155 Strongest U.S. Remplir Sales Month Since Launch 2 Nov 2026 8:32AM $0.550 $0.570 risen by 3.64%
$155 Q1 FY27 OCC Investor Presentation 22 Oct 2026 9:00AM $0.600 $0.570 fallen by 5%
$155 Quarterly Activity Report & Appendix 4C 22 Oct 2026 8:57AM $0.600 $0.570 fallen by 5%
$155 Orthocell Investor Webinar Details 20 Oct 2026 8:57AM $0.650 $0.570 fallen by 12.31%
$155 Remplir Shows Excellent Early Prostatectomy Results 13 Oct 2026 9:11AM $0.670 $0.570 fallen by 14.93%
$155 Letter to Shareholders, Notice of AGM & Proxy Form 2 Oct 2026 4:16PM $0.760 $0.570 fallen by 25%
$155 Change of Auditor 2 Oct 2026 11:04AM $0.763 $0.570 fallen by 25.25%
$155 Orthocell Achieves First Remplir Sales in Thailand 21 Sep 2026 8:55AM $0.690 $0.570 fallen by 17.39%
$155 Cleansing Notice 11 Sep 2026 3:14PM $0.710 $0.570 fallen by 19.72%
$155 Application for quotation of securities - OCC 11 Sep 2026 3:08PM $0.710 $0.570 fallen by 19.72%
$155 Date of AGM & Closing Date for Director Nominations 10 Sep 2026 8:30AM $0.725 $0.570 fallen by 21.38%
$155 Appendix 4G 31 Aug 2026 12:57PM $0.730 $0.570 fallen by 21.92%
$155 Corporate Governance Statement 31 Aug 2026 12:57PM $0.730 $0.570 fallen by 21.92%
$155 Appendix 4E & Annual Report 31 Aug 2026 12:56PM $0.730 $0.570 fallen by 21.92%
$155 Orthocell Canaccord Genuity Conference Live Webcast 12 Aug 2026 8:27AM $0.800 $0.570 fallen by 28.75%
$155 Orthocell to Present at Canaccord Growth Conference 11 Aug 2026 8:45AM $0.730 $0.570 fallen by 21.92%

1 - 25 of 785 results

Page 1 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.